11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes

Journal of Endocrinology

Volumn 225, Issue 3, 2015, Pages 147-158

  Koh, Eun Hee ^a,b   Kim, Ah Ram ^a,b   Kim, Hyunshik ^b   Kim, Jin Hee ^b   Park, Hye Sun ^b   Ko, Myoung Seok ^b   Kim, Mi Ok ^b   Kim, Hyuk Joong ^a,b   Kim, Bum Joong ^a,b   Yoo, Hyun Ju ^b   Kim, Su Jung ^b   Oh, Jin Sun ^a,b   Woo, Chang Yun ^a,b   Jang, Jung Eun ^a,b   Leem, Jaechan ^a,b   Cho, Myung Hwan ^c   Lee, Ki Up ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Adipocyte hypertrophy; Adiponectin; Fatty acid oxidation; Glycolysis; Mitochondria

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADIPONECTIN; AZD 6925; DEXAMETHASONE; ETOMOXIR; GLUCOSE; LACTIC ACID; LIVER PROTECTIVE AGENT; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; OXIDOREDUCTASE INHIBITOR; UNCLASSIFIED DRUG; ADAMANTANE; AZD6925; ENZYME INHIBITOR; LIPOTROPIC AGENT; NICOTINAMIDE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GLYCOLYSIS; HYPERTROPHIC ADIPOCYTE; HYPERTROPHY; LIPID STORAGE; MALE; METABOLIC PARAMETERS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; 3T3 CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; MITOCHONDRIAL DYNAMICS; MUTANT MOUSE STRAIN; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; WHITE ADIPOSE TISSUE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 3T3-L1 CELLS; ADAMANTANE; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; ENERGY METABOLISM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLYCOLYSIS; HYPERTROPHY; LIPID METABOLISM; LIPOTROPIC AGENTS; LIVER; MALE; MICE; MICE, MUTANT STRAINS; MITOCHONDRIAL DYNAMICS; NIACINAMIDE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXYGEN CONSUMPTION;

EID: 84932125966     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-15-0117     Document Type: Article

References (44)

1. Abe Y, Sakairi T, Kajiyama H, Shrivastav S, Beeson C & Kopp JB 2010 Bioenergetic characterization of mouse podocytes. American Journal of Physiology. Cell Physiology 299 C464-C476. (doi:10.1152/ajpcell.00563.2009)
2. Adams JM II, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC & Mandarino LJ 2004 Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53 25-31. (doi:10.2337/diabetes.53.1.25)
3. Capllonch-Amer G, Lladó I, Proenza AM, Garci{dotless}a-Palmer FJ & Gianotti M 2014 Opposite effects of 17-β estradiol and testosterone on mitochondrial biogenesis and adiponectin synthesis in white adipocytes. Journal ofMolecular Endocrinology 52 203-214. (doi:10.1530/JME-13-0201)
4. Chapman K, Holmes M & Seckl J 2013 11b-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiological Reviews 93 1139-1206. (doi:10.1152/physrev. 00020.2012)
5. Chaturvedi RK & Flint Beal M 2013 Mitochondrial diseases of the brain. Free Radical Biology & Medicine 63 1-29. (doi:10.1016/j.freeradbiomed.2013. 03.018)
6. Chinetti-Gbaguidi G, Bouhlel MA, Copin C, Duhem C, Derudas B, Neve B, Noel B, Eeckhoute J, Lefebvre P, Seckl JR et al. 2012 Peroxisome proliferator-activated receptor-γ activation induces 11b-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 32 677-685. (doi:10.1161/ATVBAHA.111.241364)
7. Frohnert BI & Bernlohr DA 2013 Protein carbonylation, mitochondrial dysfunction, and insulin resistance. Advances in Nutrition 4 157-163. (doi:10.3945/an.112.003319)
8. Galván-Peña S & O'Neill LA 2014 Metabolic reprograming in macrophage polarization. Frontiers in Immunology 5 420. (doi:10.3389/fimmu.2014. 00420)
9. Garbrecht MR, Schmidt TJ, Krozowski ZS & Snyder JM 2006 11b-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites. American Journal of Physiology. Endocrinology and Metabolism 290 E653-E660. (doi:10.1152/ajpendo.00396.2005)
10. Hahn WS, Kuzmicic J, Burrill JS, Donoghue MA, Foncea R, Jensen MD, Lavandero S, Arriaga EA & Bernlohr DA 2014 Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics. American Journal of Physiology. Endocrinology and Metabolism 306 E1033-E1045. (doi:10.1152/ajpendo. 00422.2013)
11. Haluzi{dotless}k M, Pari{dotless}zková J & Haluzi{dotless}k MM 2004 Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiological Research/Academia Scientiarum Bohemoslovaca 53 123-129.
12. Haschemi A, Kosma P, Gille L, Evans CR, Burant CF, Starkl P, Knapp B, Haas R, Schmid JA, Jandl C et al. 2012 The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metabolism 15 813-826. (doi:10.1016/j.cmet. 2012.04.023)
13. Hill BG, Benavides GA, Lancaster JR Jr, Ballinger S, Dell'Italia L, Jianhua Z & Darley-Usmar VM 2012 Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biological Chemistry 393 1485-1512. (doi:10.1515/hsz-2012-0198)
14. Huh JY, Kim Y, Jeong J, Park J, Kim I, Huh KH, Kim YS, Woo HA, Rhee SG, Lee KJ et al. 2012 Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. Antioxidants & Redox Signaling 16 229-243. (doi:10.1089/ars.2010.3766)
15. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, TabataMet al. 2010 Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2C and AMPK/SIRT1. Nature 464 1313-1319. (doi:10.1038/nature08991)
16. Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O, Shah YM & Gonzalez FJ 2011 Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 60 2484-2495. (doi:10.2337/db11-0174)
17. Kern PA, Di Gregorio GB, Lu T, Rassouli N & Ranganathan G 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52 1779-1785. (doi:10.2337/diabetes.52.7.1779)
18. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G et al. 2007 Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 117 2621-2637. (doi:10.1172/JCI31021)
19. Kipari T, Hadoke PW, Iqbal J, Man TY, Miller E, Coutinho AE, Zhang Z, Sullivan KM, Mitic T, Livingstone DE et al. 2013 11b-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB Journal 27 1519-1531. (doi:10.1096/fj.12-219105)
20. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS et al. 2007 Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56 2973-2981. (doi:10.2337/db07-0510)
21. Koh EH, Kim M, Ranjan KC, Kim HS, Park HS, Oh KS, Park IS, Lee WJ, Kim MS, Park JY et al. 2010 eNOS plays a major role in adiponectin synthesis in adipocytes. American Journal of Physiology. Endocrinology and Metabolism 298 E846-E853. (doi:10.1152/ajpendo.00008.2010)
22. Kusminski CM & Scherer PE 2012 Mitochondrial dysfunction in white adipose tissue. Trends in Endocrinology and Metabolism 23 435-443. (doi:10.1016/j.tem.2012.06.004)
23. Li G, Hernandez-Ono A, Crooke RM, Graham MJ & Ginsberg HN 2011 Effects of antisense-mediated inhibition of 11b-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism. Journal of Lipid Research 52 971-981. (doi:10.1194/jlr.M013748)
24. Liu Y, Mladinov D, Pietrusz JL, Usa K & Liang M 2009 Glucocorticoid response elements and 11b-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovascular Research 81 140-147. (doi:10.1093/cvr/cvn231)
25. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ & Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141 560-563. (doi:10.1210/endo.141.2.7297)
26. Livingstone DE, Grassick SL, Currie GL, Walker BR & Andrew R 2009 Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency. Journal of Endocrinology 201 211-218. (doi:10.1677/JOE-09-0003)
27. Lumeng CN, Bodzin JL & Saltiel AR 2007 Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 117 175-184. (doi:10.1172/JCI29881)
28. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR & Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294 2166-2170. (doi:10.1126/science.1066285)
29. Medina-Gómez G 2012 Mitochondria and endocrine function of adipose tissue. Best Practice & Research. Clinical Endocrinology & Metabolism 26 791-804. (doi:10.1016/j.beem.2012.06.002)
30. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ & Seckl JR 2004 Novel adipose tissuemediated resistance to diet-induced visceral obesity in 11b-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53 931-938. (doi:10.2337/diabetes.53.4.931)
31. O'Neill LA & Hardie DG 2013 Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493 346-355. (doi:10.1038/nature11862)
32. Otani H 2011 Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidants & Redox Signaling 15 1911-1926. (doi:10.1089/ars.2010.3739)
33. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H et al. 2001 Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 1057-1063. (doi:10.1161/01.CIR.103.8.1057)
34. Ryu MJ, Kim SJ, Kim YK, Choi MJ, Tadi S, Lee MH, Lee SE, Chung HK, Jung SB, Kim HJ et al. 2013 Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. PLoS Genetics 9 e1003356. (doi:10.1371/journal.pgen.1003356)
35. Scott JS, Barton P, Bennett SN, deSchoolmeester J, Godfrey L, Kilgour E, Mayers RM, Packer MJ, Rees A, Schofield P et al. 2012 Reduction of acyl glucuronidation in a series of acidic 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) inhibitors: the discovery of AZD6925. Medicinal Chemistry Communication 3 1264-1269. (doi:10.1039/c2md20154b)
36. Seckl JR & Walker BR 2001 Minireview: 11b-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 142 1371-1376. (doi:10.1210/endo.142.4.8114)
37. Thieringer R, Le Grand CB, Carbin L, Cai TQ, Wong B, Wright SD & Hermanowski-Vosatka A 2001 11b-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. Journal of Immunology 167 30-35. (doi:10.4049/jimmunol.167.1.30)
38. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S et al. 2006 TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. Journal of Clinical Investigation 116 2791-2798. (doi:10.1172/JCI28570.)
39. Véniant MM, Hale C, Komorowski R, Chen MM, St Jean DJ, Fotsch C & Wang M 2009 Time of the day for 11b-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice. Diabetes, Obesity & Metabolism 11 109-117. (doi:10.1111/j.1463-1326.2008.00911.x)
40. Walker BR, Soderberg S, Lindahl B & Olsson T 2000 Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. Journal of Internal Medicine 247 198-204. (doi:10.1046/j.1365-2796.2000.00609.x)
41. Wang Y, Lam KS, Chan L, Chan KW, Lam JB, Lam MC, Hoo RC, Mak WW, Cooper GJ & Xu A 2006 Posttranslational modifications on the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high-molecular-weight oligomeric complex. Journal of Biological Chemistry 281 16391-16400. (doi:10.1074/jbc.M513907200)
42. Wang CH, Wang CC, Huang HC & Wei YH 2013 Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS Journal 280 1039-1050. (doi:10.1111/febs.12096)
43. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J et al. 2003 Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry 278 2461-2468. (doi:10.1074/jbc.M209033200)
44. Ye J, Gao Z, Yin J & He Q 2007 Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. American Journal of Physiology. Endocrinology and Metabolism 293 E1118-E1128. (doi:10.1152/ajpendo. 00435.2007)